Hybrid immunoglobulins

Details Hybrid immunoglobulins Hybrid immunoglobulins

1992-12-08

1995-06-27

Hill, Jr., Robert J.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

5303871, 536 234, 435 647, C07K 1300

Patent

active

054281300

ABSTRACT:
Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.

REFERENCES:
patent: 5116964 (1992-05-01), Capon et al.
DNA and Prot. Eng. 2:1-3(1990) Cosman, D. Expression Cloning of Cytokine and Cytokine Receptors by Screening Pools of cDNA Clones.
DNA and Prot. Eng, 2:3-25 (1990) Gorman et. al Transient Production of Proteins Using an Adenovirus Transformed Cell Line.
Ashkenazi, A. et al., "Protection Against Endotoxic Shock by a Tumor Necrosis Factor Receptor Immunoadhesin," Proc. Natl. Acad. Sci. USA 88: 10535-10539 (1991).
Bennett, B. et al., "Extracellular domain-IgG Fusion Proteins for Three Human Natriuretic Peptide Receptors," J. Biol. Chem. 266(34): 23060-23067 (1991).
Byrn, R. et al., "Biological Porperties of a CD4 Immunoadhesin," Nature 344: 667-670 (1990).
Capon, D. et al., "Designing CD4 Immunoadhesins for AIDS Therapy," Nature 337: 525-531 (1989).
Haak-Frendscho, M. et al., "Inhibition of Interferon-.gamma. by an Interferon-.gamma. Receptor Immunoadhesin," Immunology 79 (1993).
Lesslauer, W., et al., "Recombinant Soluble Tumor Necrosis Factor Receptor Proteins Protect Mice From Lipopolysaccharide-Induced Lethality," Eur. J. Imunol. 21: 2883-2886 (1991).
Mark, M. et al., "Expression and Characterization of Hepatocyte Growth Factor Receptor-IgG Fusion Proteins," J. Biol. Chem. 267(36): 26166-26171 (1992).
Naldini, L. et al., "Scatter Factor and Hepatocyte Growth Factor Are Indistinguishable Ligands for the MET Receptor," EMBO J. 10: 2867-2878 (1991).
Peppel, K. et al., "A Tumor Necrosis Factor (TNF) Receptor-IgG Heavy Chain Chimeric Protein as a Bivalent Antagonist of TNF Activity," J. Exp. Med. 174: 1483-1489 (1991).
de Sauvage, F., et al., "Primary Structure and Functional Expression of the Human Receptor for Escherichia coli Heat-Stable Enterotoxin," J. Biol. Chem. 266(27): 17912-17918 (1991).
Williams et al., Gene 43:319-324, (1986).
Becker et al., Cell 58:911-921 (1989).
Mariuzza et al., J. Biol. Chem. 264:7310-7316 (1981).
Morrison, s. L., Science 229:1202-1207 (1985).
Capon et al., Nature 337:525-531 (1989).
Gascoigne et al., Proc. Natl. Acad. Sci. USA 84:2936-2940 (1987).
Traunecker et al., Nature 339:68-70 (1989).
Knapp et al., Immunology Today 10(8):253-258 (1989).
Neuberger et al., Nature 312:605-608 (1984).
Munro, A., Nature 312:597 (1984).
Sharon et al., Nature 309:364-367 (1984).
Morrison et al., Proc. Natl. Acad. Sci. USA 81:6851-6855 (1984).
Boullianne et al., Nature 312:643-646 (1984).
Traunecker et al., Nature 331:84-86 (1988).
Traunecker et al., Eur. J. Immunol. 16:851-859 (1986).

Affiliated with

Also associated with

Rating

Hybrid immunoglobulins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybrid immunoglobulins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid immunoglobulins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-288383